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Summary
Background.— Conventional coronary angiography (CA) is still recommended before valvu-
lar surgery. Preliminary studies suggest that multislice spiral computed tomography coronary
angiography (MSCT-CA) can be used to rule out coronary artery disease (CAD).
Abbreviations: ASE, Agatston score equivalent; CAD, coronary artery disease; CA, coronary angiography;
I, conﬁdence interval; CT, computed tomography; MSCT-CA, multislice spiral computed tomography coronary angiography.
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Conclusion.— Quand le score calcique est inférieur à 1000, le scanner coronaire est sûr et
pourrait être recommandé en première intention avant la coronarographie chez les patients
e aortique sévère.
Tous droits réservés.
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Background
In all forms of valvular heart disease, signiﬁcant associ-
ated CAD worsens the perioperative prognosis. CA is still
recommended in the preoperative assessment of patients
with valvular heart disease (Grade 1 American College
of Cardiology/American Heart Association guidelines 1998
and 1999; Grade 1 European Society of Cardiology 2007
[1—3]), although no large-scale clinical trial has assessed
the contribution of this invasive investigation. We published
a preliminary study [4] that suggested that MSCT-CA might
serve as an alternative to invasive coronary angiography
in patients scheduled for aortic valve replacement. MSCT-
CA was compared with conventional CA. In patients with
a calcium score of < 1000, the sensitivity of the MSCT-CA in
detecting signiﬁcant stenosis was 100% and its speciﬁcity was
a
i
p0%. The positive and negative predictive values were 55 and
00%, respectively. The objective of the present study was to
ssess prospectively the perioperative myocardial ischaemic
utcome of patients undergoing valve surgery, after ruling
ut signiﬁcant CAD solely on the basis of a normal MSCT-CA
esult.
ethods
his was a single-centre, prospective, diagnostic, man-
gement outcome study. The institutional review boardraphy and aortic valve surgery 171
Aim.— To assess prospectively the safety of ruling out CAD before surgery solely on the basis
of normal MSCT-CA in patients with severe aortic valve disease.
Methods.— We included all consecutive patients scheduled for aortic valve surgery. We ﬁrst
estimated the calcium score (Agatston score equivalent [ASE]). Patients underwent injected
MSCT if the ASE was < 1000. CA was cancelled when MSCT-CA quality was sufﬁcient and showed no
signiﬁcant CAD. Our primary endpoint was the occurrence of perioperative myocardial infarction
in patients who underwent surgery with no prior CA.
Results.— Between 1st July 2005 and 30th June 2008, we included 199 patients with severe
aortic valve disease: 118 men (59%); mean age 69± 12 years; 63 patients (32%) underwent CA
directly because the ASE was ≥ 1000. Of 136 patients who underwent MSCT-CA, 106 (78%) had a
normal MSCT-CA and underwent aortic valve surgery without prior CA; CA was performed in 30
patients because of abnormal (n = 18) or bad quality (n = 12) MSCT-CA. One patient of the 106
(0.94%, 95% conﬁdence interval 0.17—5.15) had a perioperative myocardial infarction.
Conclusions.— When the ASE is < 1000, MSCT is safe and may be recommended instead of CA
as a ﬁrst-line means of ruling out CAD in patients with severe aortic valve disease.
© 2010 Elsevier Masson SAS. All rights reserved.
Résumé
Préambule.— Une coronarographie est généralement réalisée avant une chirurgie valvulaire.
Des études préliminaires, prenant la coronarographie comme référence, ont suggérées que le
scanner coronaire pouvait exclure une coronaropathie. Nous avons évalué de manière prospec-
tive la sécurité de l’exclure sur la seule base d’un scanner normal avant chirurgie valvulaire
aortique.
Méthode.— Inclusion des patients consécutifs programmés pour une chirurgie de la valve aor-
tique. Premièrement, estimation du score calcique selon la méthode d’Agatston. Les patients
ne bénéﬁciaient du scanner injecté que lorsque le score calcique était inférieur à 1000. La
coronarographie était annulée quand le scanner était de bonne qualité et permettait d’exclure
une coronaropathie signiﬁcative. Le critère primaire était la survenue périopératoire d’un IDM
chez les patients n’ayant pas subi de coronarographie.
Résultats.— Entre juillet 2005 et juin 2008, nous avons inclus 199 patients avec valvulopathie
aortique sévère : hommes, 118 (59 %) ; âge = 69± 12 ans ; 63 patients ont subi la coronarographie
d’emblée en raison d’un score calcique supérieur ou égal à 1000. Sur les 136 ayant bénéﬁcié du
scanner avec injection, 106 (78 %) avaient des coronaires saines et ont été opérés sans coro-
narographie préalable, alors qu’une coronarographie a du être réalisée chez 30 patients pour
anomalies au scanner (n = 18) ou mauvaise qualité (n = 12). Un seul patient sur 106 a présenté
un IDM périopératoire (0,94 %, IC 95% [0,17—5,15]).pproved the study and all patients provided written
nformed consent.
From 1st July 2005 to 30th June 2008, all consecutive
atients aged 18 years and over who were referred to our
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ardiology department for CA in the preoperative assess-
ent of aortic valve disease (stenosis or regurgitation) were
onsidered for inclusion. Exclusion criteria were: irregular
eart rate; iodinated contrast agent contraindication; renal
nsufﬁciency; and already rejected for valve surgery for non-
AD reasons.
Our main objective was to validate prospectively the
uling out of signiﬁcant CAD on the basis of a normal or
ubnormal MSCT-CA result.
We assumed that patients with a normal or subnormal
oronary artery network have a perioperative risk of an
schaemic cardiac event of approximately 1% [5]; in a pre-
iminary study [4], we detected ‘‘normal’’ patients with a
egative predictive value of 100% compared with CA; in the
ame study, we found that CA could have been avoided in
5/55 cases.
Therefore, 110 patients with a normal MSCT-CA were
eeded, given the hypothesis that none or one of them
approximately 1%) would present with a cardiac ischaemic
vent during the perioperative period, allowing us to obtain
n upper limit of the 95% conﬁdence interval (CI) of
5% for the risk of an ischaemic event (Euro Heart Sur-
ey) [5]. In accordance with our previous data to obtain
10 patients with a calcium score < 1000 and a nor-
al or subnormal MSCT-CA we planned to include 205
atients.
Except for MSCT-CA and (possibly) CA, clinicians in charge
f the patient were allowed to perform any other preopera-
ive evaluation. They made the decision to schedule surgery
r reject the patients. Patients not operated on within 6
onths after the initial evaluation (including preoperative
SCT-CA) were excluded from the analysis.
SCT protocol and image reconstruction
he MSCT data sets were acquired using a 16-slice MSCT
Philips Mx8000 IDT 16, Eindhoven, The Netherlands). Brieﬂy,
native scan without contrast medium was performed to
etermine total coronary calcium. A calciﬁed lesion was
eﬁned as an area of > 3 connected pixels, > 130 Hounsﬁeld
nits, and was expressed as ASE. On the basis of previously
ublished data [4], we determined that in this particular
opulation, contrast medium injection was useless when the
SE was > 1000.
Next, a volume data set was acquired (16× 0.75mm
ross-section; gantry rotation time, 420ms; table feed,
.8mm per rotation), covering the distance from the carina
o the diaphragmatic side of the heart. The entire heart was
canned during a single breath-hold; 80—120mL of contrast
gent (Iomeron 350, Bracco SA, Milano, Italy) was injected
ontinuously at a rate of 4mL/s. Automated detection of
eak enhancement in the aortic root was used to time the
can.
Cross-sectional images were reconstructed with a slice
hickness of 0.8mm at 0.4mm intervals with retrospective
ating. A scoring method analogous to the Agatston score
6] was used to quantify coronary calcium.All data sets were analysed independently by two physi-
ians experienced in MSCT, using multiplanar reformations,
hree-dimensional reconstructions by the ‘‘volume render-
ng’’ technique and ‘‘comprehensive cardiac’’ software.
hey were asked to give a consensus on the presence of
s
e
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igniﬁcant CAD on a per patient basis. Image quality was
lassiﬁed as ‘‘good’’ (no or only minor motion artefacts),
‘moderate’’ (substantial motion artefacts), or ‘‘bad’’ (sig-
iﬁcant motion artefacts and/or low signal-to-noise ratio
nd no luminal assessment of signiﬁcant stenosis possible in
t least one vessel). In addition, the observers were asked to
tate their recommendations for patient management (i.e.,
A indicated or not).
CA was performed when recommended on the same
ay after MSCT if the ASE was > 1000, and 2 days later
f the MSCT was of bad quality or if signiﬁcant CAD was
uspected. Angiograms were evaluated by an independent
bserver, blinded to the MSCT-CA results, using quantita-
ive CA (Numeric System, DX-DLX, General Electric Medical
ystems, Buc, France) as the gold standard of stenosis detec-
ion. Lesions with a ≥ 50% diameter reduction counted as
igniﬁcant stenosis.
ollow-up
ll patients were followed for 30 days after aortic valve
urgery. Perioperative myocardial infarction was deﬁned as
signiﬁcant elevation (≥ 20 ng/mL) of plasma troponin
c during the ﬁrst 24 hours after surgery and no other
lear explanation. During the postsurgery period, myocar-
ial infarction was deﬁned by the association of chest
ain, new onset Q waves and troponin Ic elevation (≥ 0.2
g/mL above the last measurement) [7,8]. The outcome
vents were judged by an adjudication committee, com-
rising three independent experts who were blinded to the
ests performed before surgery. In cases of death or sus-
ected myocardial infarction within the 30-day period, the
atient chart was reviewed, and death and troponin eleva-
ion were judged as being related or unrelated to a coronary
rtery ischaemic event. Unrelated events were due to obvi-
us perioperative causes, such as a drawback in myocardial
rotection (isolated troponin Ic elevation with no Q waves
nd no wall-motion abnormality).
tatistical analysis
eneral characteristics, CAD risk factors and clinical signs
ere expressed as means and standard deviations for contin-
ous variables and as percentages for qualitative variables.
he rates of myocardial infarction and death during follow-
p in patients undergoing aortic valve surgery with no prior
A on the basis of a normal MSCT-CA were assessed with their
espective 95% CIs. All analyses used SPSS analysis software,
ersion 12.0 (SPSS Inc., Chicago, IL, USA).
esults
he patient ﬂowchart is presented in Fig. 1. From 1 July 2005
o 30 June 2008, 215 patients were considered for inclusion
n the study. As speciﬁed previously, we excluded a poste-
iori 16 patients from the analysis, as they did not undergo
urgery within a period of 6 months after initial preoperative
valuation.
The patients’ general characteristics were as follows:
18 men (59%); mean age, 69± 12 years; mean heart rate,
8± 9 beats per minute; previous oral treatment with beta-
Multislice spiral computed tomography and aortic valve surgery 173
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MFigure 1. Patient management ﬂowchart (MSCT-CA: multislice sp
blockers, n = 40 (20%); and intravenous beta-blockers before
injection, n = 28 (14%). Of the 199 patients included, 63
(31.66%) with an ASE > 1000 did not undergo CT opaciﬁ-
cation and underwent CA on the same day. Of the 136
patients with an ASE < 1000 and who underwent MSCT-
CA, CA was also performed 2 days after MSCT-CA in 12
patients (6.0%) because of the bad quality of the MSCT
and in 18 patients (9.0%) because of abnormalities in the
coronary artery network detected by MSCT-CA. The remain-
ing 106 patients (78% of patients with an ASE < 1000)
had a normal MSCT-CA (good quality, n = 85; intermedi-
ate quality, n = 21) and underwent aortic valve surgery
without prior CA. The baseline characteristics of these
patients are summarized in Table 1. Of these 106 patients,
six underwent a Ross’s intervention, three underwent a
Tyrone David’s intervention and seven a Bentall’s procedure.
Finally, 49 biological and 48 mechanical prostheses were
implanted.
The calcium score was 0 for 42 patients, 38 of whom had
a normal injected MSCT. In four cases, quality was poor and
CA was performed and was normal in all cases. Finally, 93
patients underwent CA, which was considered normal (no
signiﬁcant stenosis) in 39 cases and abnormal in 54 cases.
Only 33 of these 54 patients beneﬁted from a coronary revas-
cularization; the others had distal severe lesions.
One patient died during surgery (a 77-year-old woman
who died after a perioperative right ventricular injury that
was impossible to repair; 0.94%, 95% CI 0.17—5.15).
a
s
p
eomputed tomography coronary angiography).
ollow-up
he mean postsurgery troponin I concentration was
.17± 26.3 ng/mL.
Of the 199 patients ﬁnally included and analysed, seven
ad a suspected acute myocardial infarction after surgery.
he adjudication committee reviewed all of these patients’
harts, blinded to the results of the preoperative CAD assess-
ent: three had a normal preoperative MSCT-CA, one had a
ormal CA and three had an abnormal CA (in these cases
urgical revascularization was associated with the valve
eplacement). Of the three patients with a normal MSCT-
A, only one was considered to have had a perioperative
yocardial infarction, whereas two patients had a drawback
n myocardial protection during aortic cross-clamping time.
hese two patients had elevated troponin I concentration
ithout Q waves on the electrocardiogram and no wall-
otion abnormality on the echocardiogram (the calcium
core was 0 for one of them). In both cases, the myocardial
rotection problem was noted in the surgery report. The
atient who had a myocardial infarction had a mild stenosis
n the ﬁrst diagonal artery that had been reported on the
SCT-CAD but had been considered to be non-signiﬁcant on
small artery. The postoperative CA conﬁrmed the occlu-
ion of the diagonal artery at the level of the stenosis. No
ercutaneous intervention was performed.
Of the 106 patients, none suffered from an ischaemic
vent during the 30-day follow-up period but two patients
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Table 1 Baseline characteristics of the 106 patients
who had a normal multislice spiral computed tomography
coronary angiogram.
Characteristic
Age (years) 68.4± 12
Men 55.0
Creatinine clearance (mL/min/m2) 74.3± 16
Risk factors
Body mass index 25.6± 4.2
Smokers 37.7
Dyslipidaemia 45.7
Diabetes 11.0
Family history of coronary artery disease 11.0
Hypertension 49.7
Severe aortic stenosis (n = 89)
Valve area (cm2) 0.64± 0.15
Mean gradient (mmHg) 54.8± 14
LVEF (%) 64± 13
Annuloaortic ectasia (n = 6)
LVEF (%) 58± 11
Major aortic regurgitation (n = 11)
LVEF (%) 63± 12
Multislice spiral computed tomography
Dose length product (mGy/cm) 672± 100
Data are mean± standard deviation or %.
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in these indications.LVEF: left ventricular ejection fraction.
ied: one had a haemorrhagic stroke on day 1, the other died
n day 12 from septic shock. Thus, the ﬁnal 30-day myocar-
ial infarction rate was 1/106 (0.94%, 95% CI 0.17—5.15) and
he 30-day death rate was 3/106 (2.8%, 95% CI 1.0—8.0).
Considering only those patients who underwent CA,
9/39 (100%) patients with a normal test underwent surgery
ith no ischaemic event, but one had a signiﬁcant increase
n troponin blood concentration due to a lack of myocar-
ial protection. Three patients with signiﬁcant CAD had a
yocardial infarction (3/54: 5.6%, 95% CI 1.9—15.1).
Considering patients with an ASE > 1000 (who all under-
ent CA), the ﬁnal 30-day myocardial infarction rate was
/63 (3.2%, 95% CI 0.9—10.9). These two patients beneﬁted
rom combined surgery with coronary artery revasculariza-
ion.
iscussion
n this prospective management outcome study, a normal
r subnormal MSCT-CA allowed us to avoid CA in 106/199
53%) patients referred to our centre for the preoperative
valuation of CAD before aortic valve surgery. One patient
xperienced a perioperative myocardial infarction. This rate
0.94%, 95%CI 0.17—5.15) is concordant with data published
reviously on perioperative ischaemic events in European
atients with previous normal or subnormal coronary angiog-
aphy [5].
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Cardiac MSCT is a rapidly evolving technique that allows
oninvasive depiction of the epicardial coronary circulation.
huge amount of literature is being published on this tech-
ique. Most evaluations compare CT with the gold standard
oronary angiography on a per segment or a per patient anal-
sis. As the technique has improved, data using 4-section CT
9], 16-section CT, 64-section CT [10], and now dual-source
T [11] have become available, emphasizing the good neg-
tive predictive value of the test. Most of these data were
cquired by trained teams in single-centre studies. This is
ne limitation of our study: it was done in a single centre
ith trained physicians doing a double analysis of each CT.
Data from multicentre studies are rare and possibly less
ptimistic [12]. Nevertheless, in clinical practice, the most
mportant factor is no longer the comparison with the ref-
rence test but the clinical outcome follow-up in various
linical indications. Gilard et al. [13] suggested that it was
afe to use a normal or subnormal MSCT to rule out signiﬁ-
ant CAD in patients with atypical chest pain or discordant
tress tests; this allowed them to be managed less invasively,
y reducing the number who required CA. The risks of sub-
equent death (0%), new referral for CA (3.5%) or coronary
vents (0.7%) compared favourably with those after normal
A, which were 0.4%, 4.3%, and 0.6%, respectively.
Another study published by Gilard et al. [4] evaluated
he ability of MSCT-CA to rule out signiﬁcant CAD in 55
atients scheduled for CA in the preoperative evaluation
f CAD before aortic valve replacement. For all patients,
SCT-CA ﬁndings were compared with CA as the gold stan-
ard. The sensitivity of the MSCT-based strategy in detecting
igniﬁcant stenosis was 100%. The results of this initial study
n a small number of patients suggested that MSCT-CA might
erve as an alternative to CA in the preoperative evalua-
ion of CAD in patients with aortic valve stenosis. Laissy et
l. [14] and Reant et al. [15], in a per segment analysis,
howed that MSCT-CA had a 93% and 99% negative predic-
ive value, respectively, compared with CA, for ruling out
igniﬁcant CAD in comparable populations. The next step in
he validation of MSCT-CA in this particular indication (in
rder to avoid performing CA in cases of normal or subnor-
al MSCT-CA and to rule out signiﬁcant CAD on the sole basis
f a normal or subnormal MSCT-CA), was to perform a man-
gement outcome study — that is, a study in which clinical
ecision is based on this test alone.
In the Euro Heart Survey on Valvular Heart Disease [5],
A was performed in 84.9% of operated patients. Reasons
dvocated for not performing CA were: absence of car-
iovascular risk factor (31.3%); acute endocarditis; poor
aemodynamic conditions; no catheterization facility avail-
ble; and absence of evidence of ischaemia. Perioperative
yocardial infarction was rare (1%) in the population with
o associated coronary artery revascularization but was not
ero. Most acute coronary syndromes occur by rupture or
rosion of ‘‘high-risk plaques’’ that are not signiﬁcantly
tenotic in more than two-thirds of cases; thus, it will never
e possible to detect 100% of high risk patients using pure
natomical imaging tests. Molecular imaging might help soonThere are many advantages to performing CT instead of
A in the preoperative evaluation of patients with severe
ortic valve disease. The cost of CT is probably much less
han CA in all countries and local complications are rare.
ery
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Heart 2007;93:1121—5.Multislice spiral computed tomography and aortic valve surg
There is no necessity for hospitalization so all the pre-
operative assessment can be performed in the outpatient
setting. Cost and radiation exposure of calcium scoring are
low and only patients with a poor quality or abnormal MSCT-
CA (30/199 in our study; 15.1%) need undergo both MSCT-CA
and CA. Cardiac multidetector CT is a rapidly evolving tech-
nique that needs strong clinical evaluation to support its
worldwide use. Many studies validate its high negative pre-
dictive value compared with CA ﬁndings. The primary reason
for performing CAD assessment before valve surgery is to
avoid perioperative ischaemic events. Obviously, long-term
follow-up was not performed in this study and patients were
not randomized, so it was not possible to compare long-term
occurrence of ischaemic events after a normal CA or a nor-
mal MSCT. This kind of randomized comparison might be the
next and ﬁnal step to provide sufﬁcient data to justify MSCT
being incorporated into future guidelines.
Conclusion
In this prospective study, we showed that it was as safe to
perform aortic valve surgery after a normal or subnormal
MSCT-CA as after a normal or subnormal CA. This approach
could avoid the need for CA in more than 50% of cases and
it might be integrated soon into the guidelines on the man-
agement of severe aortic valve disease.
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